Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.
Sayitoglu M, Haznedaroğlu IC, Hatirnaz O, Erbilgin Y, Aksu S, Koca E, Adiguzel C, Bayik M, Akalin I, Gülbas Z, Akay M, Unal A, Kaynar L, Ovali E, Yilmaz M, Yenerel M, Dagdas S, Ozet G, Ar C, Aydin Y, Soysal T, Durgun B, Ozcebe O, Tukun A, Ilhan O, Ozbek U.
Sayitoglu M, et al. Among authors: kaynar l.
J Int Med Res. 2009 Jul-Aug;37(4):1018-28. doi: 10.1177/147323000903700406.
J Int Med Res. 2009.
PMID: 19761684
Free article.
Clinical Trial.